
China SXT Pharmaceuticals SXTC
€ 1.64
2.52%
Geschäftsbericht 2025
hinzugefügt 11.04.2026
China SXT Pharmaceuticals DPO 2011-2026 | SXTC
DPO Jährlich China SXT Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 324 | 353 | 338 | 397 | 320 | 269 | 128 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 397 | 128 | 304 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
55 | $ 320.13 | -3.98 % | $ 41.9 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 21.81 | 0.6 % | $ 1.02 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Akebia Therapeutics
AKBA
|
168 | $ 1.35 | -12.9 % | $ 347 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.26 | 0.47 % | $ 456 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 24.19 | -1.59 % | $ 3.08 B | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.61 | 8.05 % | $ 428 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
BioXcel Therapeutics
BTAI
|
34.2 K | $ 1.07 | 1.9 % | $ 13.1 M | ||
|
ChromaDex Corporation
CDXC
|
76.3 | - | -0.88 % | $ 598 M |